Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A3 | P48764 | 14/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15267578 | 0.94 | SLC9A3 (0.63) | SLC9A3 | |
| SCHEMBL13467244 | 0.93 | SLC9A3 (0.64) | SLC9A3 | |
| SCHEMBL19593911 | 0.84 | SLC9A3 (0.65) | SLC9A3 | |
| SCHEMBL13286076 | 0.82 | SLC9A3 (0.63) | SLC9A3 | |
| SCHEMBL20953590 | 0.82 | SLC9A3 (0.71) | SLC9A3 | |
| SCHEMBL13276314 | 0.81 | SLC9A3 (0.62) | SLC9A3 | |
| SCHEMBL2566213 | 0.81 | SLC9A3 (0.62) | SLC9A3 | |
| SCHEMBL13467111 | 0.81 | SLC9A3 (0.62) | SLC9A3 | |
| SCHEMBL23469853 | 0.80 | SLC9A3 (0.57) | SLC9A3 | |
| SCHEMBL2573261 | 0.80 | SLC9A3 (0.81) | SLC9A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200368223-A1 | METHODS FOR INHIBITING PHOSPHATE TRANSPORT | ARDELYX, INC. (US) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200368223-A1 | METHODS FOR INHIBITING PHOSPHATE TRANSPORT | SLC34A3, SLC34A2, SLC34A1 | SLC9A3 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.